Stocks TelegraphStocks Telegraph
Stock Ideas

Mike Matson

Needham | Healthcare

Mike Matson is an analyst from Needham specializing in the Healthcare sector. Ranked #2021 out of 4631 analysts, they have issued 78 stock ratings with a success rate of 89.06% and an average return of 5.19%.

Mike Matson has a well-established track record, with 78 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 89.06% and an average return of 5.19%, underscoring their expertise and ability to identify winning opportunities for investors.

#2021
Out of 4631
78
Total Ratings
+89.06%
Success Rate
+5.19%
Average Return

Recent Ratings Analysis

BSX

Buy

Apr 23, 2026

Target

$77.00

Current

$64.87

Performance

—

Mike Matson rated BSX as Buy on Apr 23, 2026, setting a price target of 77. Shares have remained stable near 64.87, leaving the 77 target still in play.

AORT

Buy

Apr 07, 2026

Target

$58.00

Current

$37.03

Performance

5.14%

On Apr 07, 2026, AORT was given a Buy rating by Mike Matson, with a target price of 58. The stock rallied 5.14% after the rating, narrowing the gap to the target of 58 and validating the bullish stance.

VCYT

Buy

Apr 01, 2026

Target

$48.00

Current

$33.71

Performance

4.04%

VCYT received a Buy rating from Mike Matson on Apr 01, 2026, aiming for 48. Price action was muted, as shares hovered around 33.71 despite the bullish outlook.

MMSI

Buy

Apr 01, 2026

Target

$101.00

Current

$69.72

Performance

2.18%

On Apr 01, 2026, Mike Matson published a Buy outlook on MMSI, with a target of 101. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 69.72.

MDT

Buy

Mar 26, 2026

Target

$120.00

Current

$83.22

Performance

—

Mike Matson on Mar 26, 2026 assigned MDT a Buy rating, with a price target of 120. The recommendation remains pending validation as shares consolidate around 83.22.

LUCD

Buy

Mar 26, 2026

Target

$3.00

Current

$1.31

Performance

—

On Mar 26, 2026, Mike Matson reaffirmed LUCD with a Buy rating, targeting 3. Market indecision has kept the 3 target in a holding pattern.

PSNL

Buy

Feb 27, 2026

Target

$12.00

Current

$6.31

Performance

-30.35%

PSNL was rated Buy by Mike Matson on Feb 27, 2026, with a price objective of 12. This case shows how bullish projections can fail, with the stock now below 6.31.

KIDS

Buy

Feb 27, 2026

Target

$30.00

Current

$16.37

Performance

-14.61%

On Feb 27, 2026, Mike Matson initiated coverage on KIDS with a Buy rating and target of 30. The Buy call has yet to be validated as shares remain 13.63 away from the target.

TFX

Buy

Feb 26, 2026

Target

$147.00

Current

$138.81

Performance

16.63%

Mike Matson issued a Buy recommendation for TFX on Feb 26, 2026, price target set at 147. Investors following the Buy call captured upside momentum, with shares now at 138.81.

ENOV

Buy

Feb 26, 2026

Target

$52.00

Current

$23.76

Performance

-6.53%

On Feb 26, 2026, ENOV was evaluated by Mike Matson, who gave a Buy rating and target of 52. Investors saw limited payoff as shares fell short of the 52 target.

LIVN

Buy

Feb 25, 2026

Target

$81.00

Current

$65.18

Performance

-7.27%

Mike Matson rated LIVN as Buy on Feb 25, 2026, setting a price target of 81. The stock has underperformed, dropping 7.27% despite the bullish target of 81.

TMDX

Buy

Feb 25, 2026

Target

$174.00

Current

$114.65

Performance

-13.05%

On Feb 25, 2026, TMDX was given a Buy rating by Mike Matson, with a target price of 174. Despite the Buy call, shares fell from 114.65 to 114.65, challenging the optimistic stance.

ESTA

Buy

Feb 24, 2026

Target

$86.00

Current

$67.09

Performance

-15.79%

ESTA received a Buy rating from Mike Matson on Feb 24, 2026, aiming for 86. The rating hasn’t played out as hoped, with the stock trading 15.79% below expectations.

NEO

Buy

Feb 17, 2026

Target

$15.00

Current

$8.18

Performance

-28.50%

On Feb 17, 2026, Mike Matson published a Buy outlook on NEO, with a target of 15. Market action contradicted the Buy thesis, as shares slipped to 8.18.

ATRC

Buy

Feb 12, 2026

Target

$45.00

Current

$27.63

Performance

-13.11%

Mike Matson on Feb 12, 2026 assigned ATRC a Buy rating, with a price target of 45. The call has struggled to gain traction, with shares losing 13.11%.

ZBH

Hold

Feb 10, 2026

Target

—

Current

$93.04

Performance

1.79%

On Feb 10, 2026, Mike Matson reaffirmed ZBH with a Hold rating, targeting null. The neutral call matched muted market action of 1.79%.

SYK

Buy

Jan 30, 2026

Target

$454.00

Current

$329.35

Performance

-10.88%

SYK was rated Buy by Mike Matson on Jan 30, 2026, with a price objective of 454. This case shows how bullish projections can fail, with the stock now below 329.35.

CNMD

Hold

Jan 29, 2026

Target

—

Current

$38.49

Performance

3.16%

On Jan 29, 2026, Mike Matson initiated coverage on CNMD with a Hold rating and target of null. The stock’s lack of movement around 38.49 aligned with a cautious approach.

PEN

Hold

Jan 16, 2026

Target

—

Current

$332.21

Performance

-5.29%

Mike Matson issued a Hold recommendation for PEN on Jan 16, 2026, price target set at null. Market action validated the conservative Hold outlook with shares at 332.21.

HAE

Hold

Dec 15, 2025

Target

—

Current

$61.13

Performance

-23.97%

On Dec 15, 2025, HAE was evaluated by Mike Matson, who gave a Hold rating and target of null. The Hold call avoided chasing into subsequent weakness of 23.97%.

IMDX

Buy

Nov 11, 2025

Target

$9.00

Current

$3.75

Performance

-50.20%

Mike Matson rated IMDX as Buy on Nov 11, 2025, setting a price target of 9. The stock has underperformed, dropping 50.20% despite the bullish target of 9.

HOLX

Hold

Oct 21, 2025

Target

—

Current

$76.01

Performance

2.74%

On Oct 21, 2025, HOLX was given a Hold rating by Mike Matson, with a target price of null. Market indecision, reflected in sideways trading near 76.01, supported the cautious call.

INMD

Hold

Oct 10, 2025

Target

—

Current

$14.41

Performance

-5.63%

INMD received a Hold rating from Mike Matson on Oct 10, 2025, aiming for null. The Hold stance proved prudent, with the market softening by 5.63%.

MASI

Hold

Apr 10, 2025

Target

—

Current

$178.53

Performance

17.85%

On Apr 10, 2025, Mike Matson published a Hold outlook on MASI, with a target of null. The Hold call missed some of the bullish momentum as shares advanced toward null.

INGN

Hold

Apr 09, 2025

Target

—

Current

$7.15

Performance

1.56%

Mike Matson on Apr 09, 2025 assigned INGN a Hold rating, with a price target of null. The Hold stance reflected consolidation, as shares held near 7.15.

ICUI

Hold

Apr 08, 2025

Target

—

Current

$127.36

Performance

-4.93%

On Apr 08, 2025, Mike Matson reaffirmed ICUI with a Hold rating, targeting null. The neutral call matched muted market action of -4.93%.

OCX

Buy

Apr 08, 2025

Target

$4.25

Current

$3.20

Performance

16.36%

OCX was rated Buy by Mike Matson on Apr 08, 2025, with a price objective of 4.25. A bullish response from the market helped close the gap of 1.05 to the target.

STE

Hold

Apr 07, 2025

Target

—

Current

$223.55

Performance

5.07%

On Apr 07, 2025, Mike Matson initiated coverage on STE with a Hold rating and target of null. The Hold stance underestimated the stock’s strength as it gained 5.07%.

RMD

Hold

Jan 31, 2025

Target

—

Current

$222.04

Performance

-5.99%

Mike Matson issued a Hold recommendation for RMD on Jan 31, 2025, price target set at null. Market action validated the conservative Hold outlook with shares at 222.04.

SRDX

Hold

Jan 30, 2025

Target

—

Current

$42.98

Performance

21.14%

On Jan 30, 2025, SRDX was evaluated by Mike Matson, who gave a Hold rating and target of null. Investors who stayed in despite the Hold saw upside of 21.14%.

FNA

Hold

Jan 29, 2025

Target

$13.00

Current

$13.09

Performance

0.77%

Mike Matson rated FNA as Hold on Jan 29, 2025, setting a price target of 13. The Hold stance appears justified, as shares hovered around 13.09 with a 0.77% move.

NARI

Hold

Oct 09, 2024

Target

—

Current

$79.97

Performance

91.82%

On Oct 09, 2024, NARI was given a Hold rating by Mike Matson, with a target price of null. The stock rallied from 79.97 to 79.97 after the Hold rating, surprising to the upside.

AXNX

Hold

May 06, 2024

Target

—

Current

$70.98

Performance

5.02%

AXNX received a Hold rating from Mike Matson on May 06, 2024, aiming for null. Investors saw gains of 5.02% that the cautious stance didn’t fully capture.

Frequency Asked Questions

Who is Mike Matson?
Mike Matson is an analyst from Needham specializing in the Healthcare sector.
What is Mike Matson's success rate?
Mike Matson currently has a success rate of +89.06%.
How many ratings has Mike Matson issued?
Mike Matson has issued 78 stock ratings so far.
What is the average return of Mike Matson's calls?
Their stock ratings have generated an average return of +5.19%.
What is Mike Matson's ranking?
Mike Matson is ranked #2021 out of 4631 analysts.
What types of ratings does Mike Matson give?
Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.
How can I follow Mike Matson?
You can follow Mike Matson by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.
What is the most recent rating by Mike Matson?
Their latest rating was a Buy on BSX issued on 2026-04-23.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

HomeAboutMeet The TeamContact UsPrivacy PolicyNewsletter

Useful Links

ScreenerMarket DataInsider TransactionsUpgrades & Downgrades52 Week Highs & LowsUnusual VolumeDividend CalendarEarnings CalendarStocks Watchlist
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph